Monitoring helps you measure weight loss, adjust dosages, and identify side effects
The 2024 Journal of Cosmetic Dermatology commentary by Andriotis and Dayan (PMC11845967) explicitly recommended this combination approach, noting that effective management of facial volume loss, skin laxity, and body contour challenges following GLP-1 weight loss requires a combination of injectable treatments, energy-based devices, and in some cases surgical interventions
It doesn't matter what I do
FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss
Oral semaglutide, however, should be taken at about the same time every day: first thing in the morning, on an empty stomach, with up to 4 oz of water
Novo Nordisks move reflects how quickly the GLP-1 market is changing